ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 2
Cytoreductive Therapy in PV Treatment Paradigm
Panelists discuss how cytoreductive therapy fits into the treatment paradigm for polycythemia vera (PV), highlighting key findings from the CYTO-PV study and its subanalysis, which inform their treatment decisions for patients with PV.
Video Player is loading.
Video content above is prompted by the following:
- Where does cytoreductive therapy fall in your treatment paradigm for patients with PV?
- Briefly comment on the original findings from the CYTO-PV study
- CYTO-PV, Subanalysis
Related Content:
